Eton Pharmaceuticals Inc.

7.75-0.3300-4.08%Vol 36.45K1Y Perf 86.46%
Apr 19th, 2021 11:08 DELAYED
BID7.75 ASK7.81
Open8.10 Previous Close8.08
Pre-Market- After-Market-
 - -%  - -
Target Price
13.50 
Analyst Rating
Strong Buy 1.00
Potential %
74.19 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     55.36
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap189.16M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
59.46 
Earnings Date
13th May 2021

Today's Price Range

7.758.15

52W Range

4.0110.30

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
7.73%
1 Month
0.75%
3 Months
-10.92%
6 Months
4.53%
1 Year
86.46%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ETON7.75-0.3300-4.08
AAPL134.950.79000.59
GOOG2 306.478.71000.38
MSFT260.33-0.4100-0.16
XOM56.12-0.5400-0.95
WFC43.950.11000.25
JNJ162.830.59000.36
FB304.28-1.9000-0.62
GE13.25-0.1400-1.05
JPM152.36-0.9400-0.61
Financial StrengthValueIndustryS&P 500US Markets
5.60
6.50
0.30
0.46
-
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
-633.30
-5 359.00
-5 206.00
-
-
RevenueValueIndustryS&P 500US Markets
-60 000.00
0.00
-
-
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.26-0.32-23.08
Q03 2020-0.26-0.31-19.23
Q02 2020-0.28-0.2317.86
Q01 2020-0.24-0.50-108.33
Q04 2019-0.29-0.1548.28
Q03 2019-0.23-0.28-21.74
Q02 2019-0.30-0.1840.00
Q01 2019--0.42-
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.19179.17Positive
6/2021 QR-0.1436.36Positive
12/2021 FY0.25135.21Positive
12/2022 FY0.30--
Next Report Date13th May 2021
Estimated EPS Next Report0.19
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume36.45K
Shares Outstanding24.41M
Trades Count532
Dollar Volume2.64M
Avg. Volume175.27K
Avg. Weekly Volume276.51K
Avg. Monthly Volume188.23K
Avg. Quarterly Volume181.86K

Eton Pharmaceuticals Inc. (NASDAQ: ETON) stock closed at 8.08 per share at the end of the most recent trading day (a -5.61% change compared to the prior day closing price) with a volume of 259.33K shares and market capitalization of 189.16M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 17 people. Eton Pharmaceuticals Inc. CEO is Sean E. Brynjelsen.

The one-year performance of Eton Pharmaceuticals Inc. stock is 86.46%, while year-to-date (YTD) performance is -0.62%. ETON stock has a five-year performance of %. Its 52-week range is between 4.01 and 10.3, which gives ETON stock a 52-week price range ratio of 59.46%

Eton Pharmaceuticals Inc. currently has a PE ratio of -5.30, a price-to-book (PB) ratio of 11.27, a price-to-sale (PS) ratio of -3 050.95, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -128.92%, a ROC of -218.70% and a ROE of -213.41%. The company’s profit margin is -%, its EBITDA margin is -5 206.00%, and its revenue ttm is $-60 000.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Eton Pharmaceuticals Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $0.19 for the next earnings report. Eton Pharmaceuticals Inc.’s next earnings report date is 13th May 2021.

The consensus rating of Wall Street analysts for Eton Pharmaceuticals Inc. is Strong Buy (1), with a target price of $13.5, which is +74.19% compared to the current price. The earnings rating for Eton Pharmaceuticals Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Eton Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Eton Pharmaceuticals Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 16.77, ATR14 : 0.63, CCI20 : 157.93, Chaikin Money Flow : 0.08, MACD : -0.33, Money Flow Index : 47.99, ROC : 15.76, RSI : 48.02, STOCH (14,3) : 71.11, STOCH RSI : 0.73, UO : 62.62, Williams %R : -28.89), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Eton Pharmaceuticals Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eight product candidates in various stages of development.

CEO: Sean E. Brynjelsen

Telephone: +1 847 787-7361

Address: 21925 West Field Parkway, Deer Park 60010-7208, IL, US

Number of employees: 17

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

67%33%

Bearish Bullish

45%55%

Bearish Bullish

64%36%

News

Stocktwits